Lacosamide Tablet, Film Coated
Product Images NDC 85742-008

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 85742-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kanchan Healthcare Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lac-12 (Lac 12)

Kaplan-Meier survival analysis chart showing the time to second PGTC seizure comparing patients treated with Lacosamide versus placebo. The graph plots proportion of patients free from seizure over time in days, including number at risk at various timepoints.*

FDA Label Image

Lacosamide-01 (Lacosamide 01)

Chemical structure of lacosamide, showing its molecular configuration with functional groups including amide, methoxy, and benzyl components.*

FDA Label Image

Lacosamide-02 (Lacosamide 02)

A bar chart titled 'Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose.' It compares seizure reduction percentages for placebo and different doses of VIMPAT (200, 400, 600 mg/day) across three studies (Study 2, Study 3, Study 4). The y-axis shows seizure reduction percentages from 0% to 45%. VIMPAT doses consistently show higher median seizure reduction than placebo, with significant differences marked by asterisks.*

FDA Label Image

Lacosamide-03 (Lacosamide 03)

A line graph titled 'Proportion of Patients by Responder Rate for Lacosamide and Placebo Groups in Studies 2, 3, and 4.' The x-axis shows percent of patients decreasing from 100 to 0, and the y-axis shows responder rate from -100% (worsening) to 100% (improvement). Four lines represent placebo, Lacosamide 200 mg/day, 400 mg/day, and 600 mg/day groups, illustrating patient response distributions across these treatments.*

FDA Label Image

Lacosamide-04 (Lacosamide 04)

Packaging label for Lacosamide Tablets, USP 50 mg, oral film-coated tablets. The box contains 60 unit-dose tablets (6 trays of 10 tablets each) and is labeled by Kanchan Healthcare Inc. The label prominently displays the dosage strength, the proprietary drug name, and manufacturer information along with barcodes and a pharmacist dispensing note.*

FDA Label Image

Lacosamide-05 (Lacosamide 05)

Packaging label for Lacosamide Tablets, USP 100 mg by Kanchan Healthcare Inc. The film-coated tablets come in a package of 60 unit-dose tablets (6 x 10). The label includes storage instructions, manufacturer details, and a barcode. The design prominently features the product name, strength, dosage form, and labeler information.*

FDA Label Image

Lacosamide-06 (Lacosamide 06)

Packaging label for Lacosamide Tablets, USP 150 mg, film-coated oral tablets. The label indicates a package containing 60 unit-dose tablets (6 strips of 10 tablets each). It is labeled by Kanchan Healthcare Inc and includes pharmacy dispensing instructions and barcodes.*

FDA Label Image

Lacosamide-07 (Lacosamide 07)

Box packaging label for Lacosamide Tablets, USP 200 mg oral film-coated tablets. The package contains 60 unit-dose tablets (6 blister cards of 10 tablets each). Labeler is Kanchan Healthcare Inc. The label includes dosing strength in green highlight, a vegetarian symbol (V), and instructions for pharmacists to dispense the accompanying Medication Guide.*

FDA Label Image

Lacosamide-08 (Lacosamide 08)

Lacosamide Tablets, USP 50 mg film-coated oral tablets label displaying the drug name, strength, and NDC 85742-008-08. The label includes storage instructions, manufacturer information (Medley Pharmaceuticals Ltd, India), and labeler details (Kanchan Healthcare Inc, New Jersey). The pack contains 60 tablets. Instruction for pharmacists to dispense accompanying medication guide is also visible.*

FDA Label Image

Lacosamide-09 (Lacosamide 09)

Lacosamide Tablets, USP 100 mg film-coated tablets label from Kanchan Healthcare Inc. The label includes storage instructions, manufacturer and distributor details, a barcode, and warnings for pharmacists to dispense the accompanying Medication Guide. The package contains 60 tablets.*

FDA Label Image

Lacosamide-10 (Lacosamide 10)

Label for Lacosamide Tablets, USP 150 mg oral film-coated tablets. The label includes storage instructions, manufacturer and labeler details: Medley Pharmaceuticals Ltd (India) and Kanchan Healthcare Inc (USA). The package contains 60 tablets and includes a barcode and dosage guidance note for pharmacists.*

FDA Label Image

Lacosamide-11 (Lacosamide 11)

Label for Lacosamide Tablets, USP 200 mg oral film-coated tablets supplied in a package of 60 tablets. The label includes dispensing instructions for pharmacists, storage conditions, and manufacturing details showing Medley Pharmaceuticals Ltd. and Kanchan Healthcare Inc. It features a barcode and space for expiration and lot information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.